Kamiya Naoto, Kishimoto Takashi, Suzuki Hiroyoshi, Sekita Nobuyuki, Nagai Yuichiro, Oosumi Nobuyuki, Kito Hiroki, Tochigi Naobumi, Shinbo Masataka, Nemori Ryouichi, Ichikawa Tomohiko, Igarashi Tatsuo, Ito Haruo, Ishikura Hiroshi
Department of Molecular Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Int J Cancer. 2003 Sep 10;106(4):480-485. doi: 10.1002/ijc.11272.
Degradation of collagen, or gelatinolysis, by tumor cells is one of the most important events in tumorigenesis. We investigate the possible relationship between the in situ gelatinolytic activities exerted by matrix metalloproteinases (MMPs) and clinico-pathological factors in renal cell tumor (RCT) patients. Using the film in situ zymography (FIZ) method, we determined in situ localization of MMP-like gelatinolytic activities in cancerous and normal tissues in the kidney (n = 51). To clarify the MMP(s) responsible for the gelatinolytic activity in RCTs, we examined the expressions of MMP-2 and MMP-9 in the kidney tissues by means of gelatin zymography (GZG). MMP expression was also detected by RT-PCR and Western blotting analysis. We then investigated the associations of MMP expression, as detected by GZG, with the intensity of gelatinolytic activity, as determined by FIZ. We analyzed the possible relationship of FIZ findings to several clinico-pathological factors such as tumor size, grade, vessel invasion, histologic type, stage and metastasis. FIZ demonstrated that all tumor and normal kidney tissues showed in situ gelatinase activities, and that gelatinolytic activities in RCTs were much stronger than those of normal kidney tissues. There was a statistically significant correlation between the intensity of MMP-like gelatinolytic activity and tumor size, tumor grade and vessel invasion (p < 0.05), but not between it and histological type, tumor stage or metastatic status. FIZ showed that tumor tissues in 5 of the 6 patients with fatal outcome exhibited the intense gelatinolytic pattern. Stronger in situ gelatinolytic patterns were documented in cases with higher MMP-2 expression. The molecular species of MMPs detected by GZG were confirmed by RT-PCR and Western blotting analysis. The FIZ technique enables a direct assessment of in situ gelatinolytic activity in RCT tissues. The intensity of the activity seems to affect the biology of RCT tissues. Our results also indicate a major role for MMP-2 in in situ gelatinolysis in RCT tissues.
肿瘤细胞对胶原蛋白的降解,即明胶溶解,是肿瘤发生过程中最重要的事件之一。我们研究了基质金属蛋白酶(MMPs)发挥的原位明胶溶解活性与肾细胞肿瘤(RCT)患者临床病理因素之间的可能关系。使用膜原位酶谱法(FIZ),我们确定了肾脏癌组织和正常组织中MMP样明胶溶解活性的原位定位(n = 51)。为了阐明RCT中负责明胶溶解活性的MMP,我们通过明胶酶谱法(GZG)检测了肾脏组织中MMP-2和MMP-9的表达。还通过逆转录聚合酶链反应(RT-PCR)和蛋白质印迹分析检测了MMP的表达。然后,我们研究了GZG检测到的MMP表达与FIZ测定的明胶溶解活性强度之间的关联。我们分析了FIZ结果与肿瘤大小、分级、血管侵犯、组织学类型、分期和转移等几个临床病理因素之间的可能关系。FIZ显示,所有肿瘤组织和正常肾脏组织均表现出原位明胶酶活性,且RCT中的明胶溶解活性比正常肾脏组织强得多。MMP样明胶溶解活性强度与肿瘤大小、肿瘤分级和血管侵犯之间存在统计学显著相关性(p < 0.05),但与组织学类型、肿瘤分期或转移状态之间无相关性。FIZ显示,6例预后不良患者中有5例的肿瘤组织呈现强烈的明胶溶解模式。在MMP-2表达较高病例中记录到更强的原位明胶溶解模式。通过RT-PCR和蛋白质印迹分析证实了GZG检测到的MMP分子种类。FIZ技术能够直接评估RCT组织中的原位明胶溶解活性。该活性强度似乎影响RCT组织的生物学特性。我们的结果还表明MMP-2在RCT组织原位明胶溶解中起主要作用。